Greenland Mines Ltd. Common Stock (GRML) Stock Price, News & Analysis

Company Overview

Greenland Mines Ltd develops essential medicines for the treatment of chronic diseases - cancer, cardiovascular, and neurodegenerative disorders. The Company operates as a single reporting segment focused on developing essential medicines for these chronic diseases. The Company has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and proprietary patented technologies involving melanocortin receptor-binding molecules and a gene therapy platform that introduces a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases.

Key Stats

• Today's Range: $0.21 to $0.26
• 50-Day Range: $0.21 to $0.52
• 52-Week Range: $0.21 to $1.65
• Volume: 3.94 million shs
• Average Volume: 3.47 million shs
• Market Capitalization: $35.35 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Sell

Greenland Mines Ltd. Common Stock Stock Analysis - MarketRank™

Greenland Mines Ltd. Common Stock scored higher than 18% of companies evaluated by MarketBeat, and ranked 796th out of 852 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 0.7 / 5
• Analyst Rating: Sell

Consensus Rating

Greenland Mines Ltd. Common Stock has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Greenland Mines Ltd. Common Stock has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Greenland Mines Ltd. Common Stock is -0.80, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Greenland Mines Ltd. Common Stock is -0.80, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Greenland Mines Ltd. Common Stock has a P/B Ratio of 1.97. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

5.40% of the float of Greenland Mines Ltd. Common Stock has been sold short.

Short Interest Ratio / Days to Cover

Greenland Mines Ltd. Common Stock has a short interest ratio ("days to cover") of 1.85, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Greenland Mines Ltd. Common Stock has recently decreased by 18.17%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Greenland Mines Ltd. Common Stock does not currently pay a dividend.

Dividend Growth

Greenland Mines Ltd. Common Stock does not have a long track record of dividend growth.

News and Social Media

• Score: 3.2 / 5
• News Sentiment: 0.13

News Sentiment

Greenland Mines Ltd. Common Stock has a news sentiment score of 0.13. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.87 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 8 news articles for Greenland Mines Ltd. Common Stock this week, compared to 2 articles on an average week.

Search Interest

11 people have searched for GRML on MarketBeat in the last 30 days. This is an increase of 10% compared to the previous 30 days.

MarketBeat Follows

10 people have added Greenland Mines Ltd. Common Stock to their MarketBeat watchlist in the last 30 days. This is an increase of 233% compared to the previous 30 days.

Company Ownership

• Score: 1.4 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Greenland Mines Ltd. Common Stock insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $40,250.00 in company stock.

Percentage Held by Insiders

11.30% of the stock of Greenland Mines Ltd. Common Stock is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

20.07% of the stock of Greenland Mines Ltd. Common Stock is held by institutions.

Company Calendar

• Last Earnings: 5/20/2026
• Today: 6/27/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED - DRUGS
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:GRML
• Previous Symbol: NASDAQ:KLTO
• CIK: 1907223
• Web: www.greenlandmines.com
• Phone: (833) 931-6330
• Fax: N/A
• Employees: 5
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($0.32)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$10.55 million
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -109.40%
• Return on Assets: -98.80%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 19.73
• Quick Ratio: 19.73

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.13 per share
• Price / Book: 1.97

Miscellaneous

• Outstanding Shares: 138,129,000
• Free Float: 122,520,000
• Market Cap: $35.35 million
• Optionable: N/A
• Beta: 6.94